RNAC logo

Cartesian Therapeutics (RNAC) P/E Ratio

PE Ratio

N/A

Wed, 27 Nov 2024 21:17:23 GMT

RNAC PE Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC PE Ratio Performance

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday--3.5%-3.1%-11.4%
1 m1 month--12.5%--
3 m3 months-+26.8%--
6 m6 months--26.7%--
ytdytd--12.9%--
1 y1 year--48.9%-465.9%+38.8%
5 y5 years--62.3%-15.2%-

RNAC PE Ratio High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month
3 m3 months
6 m6 months
1 y1 year
3 y3 years260.0010.33
5 y5 years260.0010.33
alltimeall time260.0010.33

Cartesian Therapeutics PE Ratio History

DateValue
DateValue
2022
28.25

FAQ

  • What is the all time high PE ratio for Cartesian Therapeutics?

What is the all time high PE ratio for Cartesian Therapeutics?

Cartesian Therapeutics all-time high price to earnings ratio is 260.00